<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Deftereos, Spyridon G</style></author><author><style face="normal" font="default" size="100%">Vrachatis, Dimitrios A</style></author><author><style face="normal" font="default" size="100%">Tolis, CHRISTOS</style></author><author><style face="normal" font="default" size="100%">Giannopoulos, Georgios</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Invasive treatment in peripheral artery disease.</style></title><secondary-title><style face="normal" font="default" size="100%">Curr Opin Pharmacol</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Curr Opin Pharmacol</style></alt-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Carotid Artery Diseases</style></keyword><keyword><style  face="normal" font="default" size="100%">Humans</style></keyword><keyword><style  face="normal" font="default" size="100%">Lower Extremity</style></keyword><keyword><style  face="normal" font="default" size="100%">peripheral arterial disease</style></keyword><keyword><style  face="normal" font="default" size="100%">Renal Artery</style></keyword><keyword><style  face="normal" font="default" size="100%">Subclavian Artery</style></keyword><keyword><style  face="normal" font="default" size="100%">Vertebral Artery</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2018 Apr</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">39</style></volume><pages><style face="normal" font="default" size="100%">113-120</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">Invasive treatment in peripheral artery disease (PAD) has evolved as a viable alternative to surgical treatment. However, beyond the common pathophysiological substrate, as far as treatment is concerned, each site of atherosclerotic disease (subclavian and vertebral arteries; carotid arteries; intracranial arterial tree; renal arteries; lower extremity arteries) features unique characteristics. Treatment options include medical treatment, endovascular management and/or surgery. Sound clinical evaluation is required as individual patient assessment often limits intervention options, while available data regarding benefits of invasive and surgical management are questioned by advances in medical treatment. In the present article, we aim to summarize existing evidence and guidance on the role of invasive procedures in PAD.</style></abstract><custom1><style face="normal" font="default" size="100%">http://www.ncbi.nlm.nih.gov/pubmed/29684850?dopt=Abstract</style></custom1></record></records></xml>